APPLIED DNA SCIENCES INC's ticker is APDNW and the CUSIP is 03815U110. A total of 6 filers reported holding APPLIED DNA SCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $86,000 | +2050.0% | 21,504 | -88.8% | 0.11% | +5300.0% |
Q1 2019 | $4,000 | +100.0% | 192,302 | -68.1% | 0.00% | – |
Q4 2018 | $2,000 | -98.5% | 602,062 | -2.3% | 0.00% | -100.0% |
Q3 2018 | $136,000 | -26.9% | 616,043 | -7.2% | 0.02% | -41.4% |
Q2 2018 | $186,000 | -42.6% | 663,878 | -48.8% | 0.03% | +52.6% |
Q1 2018 | $324,000 | +32.8% | 1,297,648 | +102.0% | 0.02% | -13.6% |
Q4 2017 | $244,000 | -57.6% | 642,289 | -25.1% | 0.02% | -42.1% |
Q3 2017 | $575,000 | -41.3% | 857,768 | -64.1% | 0.04% | -40.6% |
Q2 2017 | $980,000 | -0.5% | 2,389,305 | -1.7% | 0.06% | +20.8% |
Q1 2017 | $985,000 | -13.5% | 2,431,089 | +6.7% | 0.05% | -19.7% |
Q4 2016 | $1,139,000 | +481.1% | 2,277,612 | +3497.6% | 0.07% | +725.0% |
Q3 2015 | $196,000 | -35.9% | 63,310 | -69.2% | 0.01% | -27.3% |
Q2 2015 | $306,000 | +61.1% | 205,347 | +10.3% | 0.01% | +37.5% |
Q1 2015 | $190,000 | – | 186,095 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 857,768 | $575,000 | 0.04% |
GENERAL AMERICAN INVESTORS CO INC | 281,409 | $197,000 | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,407 | $21,000 | 0.00% |
Creative Planning | 88,500 | $62,000 | 0.00% |
UBS Group AG | 2,205 | $2,000 | 0.00% |
CIBC Private Wealth Group, LLC | 19,205 | $13,000 | 0.00% |